Finance

Beta
Lists
PYC:ASX
PYC Therapeutics Ltd
A$1.30
+1.16%
(+0.015) 1D
May 21, 4:10:19 PM GMT+10  ·   AUD
All symbols
SymbolPriceChange% Change
Generating top insights for PYC...
Open
A$1.28
High
A$1.34
Low
A$1.28
Mkt. cap
1.28B
Avg. vol.
1.64M
Volume
15.18M
52-wk high
A$1.75
52-wk low
A$0.84
EPS
-A$0.08
Shares outstanding
983.51M
No. of employees
23
News stories
From sources across the web
About PYC Therapeutics Ltd
CEORohan Hockings
Employees23
Founded2001
Headquarters-
SectorBiotechnology
Websitepyctx.com
Last report
Feb 26, 2026
Fiscal period
Q2 2026
EPS / Est. (AUD)
- / -
Revenue / Est. (AUD)
4.45M / -
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in AUD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in AUD
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Revenue
5.83M
5.83M
4.45M
4.45M
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
17.17M
17.17M
15.35M
15.35M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
2.13M
2.13M
1.71M
1.71M
Operating expense
19.30M
19.30M
17.07M
17.07M
Total operating expenses
19.30M
19.30M
17.07M
17.07M
Operating income
-13.47M
-13.47M
-12.62M
-12.62M
Other non operating income
-
-
-
-
EBT including unusual items
-12.57M
-12.57M
-11.56M
-11.56M
EBT excluding unusual items
-12.57M
-12.57M
-11.56M
-11.56M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-12.37M
-12.37M
-11.41M
-11.41M
Net profit margin
-212.16%
-212.16%
-256.44%
-256.44%
Earnings per share
-
-
-
-
Interest and investment income
910.91K
910.91K
1.07M
1.07M
Interest expense
-16.94K
-16.94K
-11.85K
-11.85K
Net interest expenses
893.98K
893.98K
1.06M
1.06M
Depreciation and amortization charges
-
-
-
-
EBITDA
-13.24M
-13.24M
-12.47M
-12.47M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more